Zhan H, Kaushansky K (2022) Megakaryocytes as the regulator of the hematopoietic vascular niche. Front Oncol 12:912060. https://doi.org/10.3389/fonc.2022.912060

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varricchio L, Hoffman R (2022) Megakaryocytes are regulators of the tumor microenvironment and malignant hematopoietic progenitor cells in myelofibrosis. Front Oncol 12:906698. https://doi.org/10.3389/fonc.2022.906698

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khatib-Massalha E, Méndez-Ferrer S (2022) Megakaryocyte diversity in ontogeny, functions and cell-cell interactions. Front Oncol 12:840044. https://doi.org/10.3389/fonc.2022.840044

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Wu D, Xia M, Li M, Sun Z, Shen B, Liu Y, Jiang E, Wang H, Su P, Shi L, Xiao Z, Zhu X, Zhou W, Wang Q, Gao X, Cheng T, Zhou J (2021) Characterization of cellular heterogeneity and an immune subpopulation of human megakaryocytes. Adv Sci (Weinh) 8(15):e2100921. https://doi.org/10.1002/advs.202100921

Article  CAS  PubMed  Google Scholar 

Livada AC, Pariser DN, Morrell CN (2023) Megakaryocytes in the lung: history and future perspectives. Res Pract Thromb Haemost 7(2):100053. https://doi.org/10.1016/j.rpth.2023.100053

Article  PubMed  PubMed Central  Google Scholar 

Koupenova M, Livada AC, Morrell CN (2022) Platelet and megakaryocyte roles in innate and adaptive immunity. Circ Res 130(2):288–308. https://doi.org/10.1161/CIRCRESAHA.121.319821

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pariser DN, Hilt ZT, Ture SK, Blick-Nitko SK, Looney MR, Cleary SJ, Roman-Pagan E, Saunders J 2nd, Georas SN, Veazey J, Madere F, Santos LT, Arne A, Huynh NP, Livada AC, Guerrero-Martin SM, Lyons C, Metcalf-Pate KA, McGrath KE, Palis J, Morrell CN (2021) Lung megakaryocytes are immune modulatory cells. J Clin Invest 131(1):e137377. https://doi.org/10.1172/JCI137377

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cunin P, Nigrovic PA (2019) Megakaryocytes as immune cells. J Leukoc Biol 105(6):1111–1121. https://doi.org/10.1002/JLB.MR0718-261RR

Article  CAS  PubMed  Google Scholar 

Leblanc R, Peyruchaud O (2016) The role of platelets and megakaryocytes in bone metastasis. J Bone Oncol 5(3):109–111. https://doi.org/10.1016/j.jbo.2016.02.007

Article  PubMed  PubMed Central  Google Scholar 

Leblanc R, Peyruchaud O (2016) Metastasis: new functional implications of platelets and megakaryocytes. Blood 128(1):24–31. https://doi.org/10.1182/blood-2016-01-636399

Article  CAS  PubMed  Google Scholar 

Chen L, Zhu C, Pan F, Chen Y, Xiong L, Li Y, Chu X, Huang G (2023) Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Front Oncol 13:1121401. https://doi.org/10.3389/fonc.2023.1121401

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Ambrosi S, Nilsson RJ, Wurdinger T (2021) Platelets and tumor-associated RNA transfer. Blood 137(23):3181–3191. https://doi.org/10.1182/blood.2019003978

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braun A, Anders HJ, Gudermann T, Mammadova-Bach E (2021) Platelet-cancer interplay: molecular mechanisms and new therapeutic avenues. Front Oncol 11:665534. https://doi.org/10.3389/fonc.2021.665534

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roweth HG, Battinelli EM (2021) Lessons to learn from tumor-educated platelets. Blood 137(23):3174–3180. https://doi.org/10.1182/blood.2019003976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lazar S, Goldfinger LE (2021) Platelets and extracellular vesicles and their cross talk with cancer. Blood 137(23):3192–3200. https://doi.org/10.1182/blood.2019004119

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morris K, Schnoor B, Papa AL (2022) Platelet cancer cell interplay as a new therapeutic target. Biochim Biophys Acta Rev Cancer 1877(5):188770. https://doi.org/10.1016/j.bbcan.2022.188770

Article  CAS  PubMed  Google Scholar 

Moneib H, Hafez H, Abdalla A, Hassanain O, Lehmann L, Haddad AE (2019) Day +100 platelet count predicts survival after allogeneic hematopoietic stem-cell transplantation in children with hematologic malignancies. Clin Lymphoma Myeloma Leuk 19(5):e221–e227. https://doi.org/10.1016/j.clml.2019.01.001

Article  PubMed  Google Scholar 

Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, Röllig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, Löwenberg B (2017) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345–1377. https://doi.org/10.1182/blood.2022016867

Article  CAS  Google Scholar 

Gökbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding A, Foà R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann O, Rijneveld A, Rousselot P, Ribera J, Bassan R (2024) Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143(19):1903–1930. https://doi.org/10.1182/blood.2023023568

Article  CAS  PubMed  Google Scholar 

Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 15:1628–1633. https://doi.org/10.1016/j.bbmt.2009.07.004

Article  PubMed  PubMed Central  Google Scholar 

Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 98:1826–1835. https://doi.org/10.3324/haematol.2013.091025

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) (2018) European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother 73:3221–3230. https://doi.org/10.1093/jac/dky286

Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, Hubacek P, Navarro D, Cordonnier C, Ward KN; 2017 European Conference on Infections in Leukaemia group (2019) Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 19:e260-e272. https://doi.org/10.1016/S1473-3099(19)30107-0

Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51:906–912. https://doi.org/10.1038/bmt.2016.130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G; Société Française de Greffe de Moëlle et Thérapie Cellulaire; Dana Farber Cancer Institute; International Bone Marrow Transplant Registry (2005) Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 106:1495-1500. https://doi.org/10.1182/blood-2004-11-4557

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21:389-401.e1. https://doi.org/10.1016/j.bbmt.2014.12.001

Article  PubMed  Google Scholar 

Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA (2021) Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther 27(8):642–649. https://doi.org/10.1016/j.jtct.2021.04.007

Article  CAS  PubMed